Skip to main content

The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited

Access & Citations

  • 2330
    Article Accesses
  • 0
    Web of Science
  • 6
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.